021-51111890
购物车（）
sales@molnova.cn
GSK269962A
CAS No. 850664-21-0
GSK269962A ( GSK 269962 )
产品货号. M17614 CAS No. 850664-21-0
GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥421 | 有现货 |
|
| 5MG | ￥664 | 有现货 |
|
| 10MG | ￥1239 | 有现货 |
|
| 25MG | ￥2616 | 有现货 |
|
| 50MG | ￥3880 | 有现货 |
|
| 100MG | ￥5573 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK269962A
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
-
产品描述GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
-
同义词GSK 269962
-
通路Angiogenesis
-
靶点VEGFR
-
受体MSK1; ROCK1; ROCK2; RSK1
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number850664-21-0
-
分子量570.61
-
分子式C29H30N8O5
-
纯度98%
-
溶解度DMSO : ≥ 30 mg/mL; 52.58 mM
-
SMILESCCn1c2cc(ncc2nc1c1nonc1N)Oc1cccc(c1)NC(=O)c1ccc(cc1)OCCN1CCOCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Doe C, et al. Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther. 2007 Jan;320(1):89-98. Epub 2006 Oct 3.
产品手册
关联产品
-
BFH-772
A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM.
-
Bevacizumab
Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
-
Semaxanib
Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC50 of 1.23 μM.
